Skip to content
Screener

Ginkgo Bioworks DNA Total Revenue

Total Revenue at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$11.99B
Charles River Laboratories logo
Charles River LaboratoriesCRL
$1B-2.7%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$4.05M-76.3%
eXoZymes, Inc. logo
eXoZymes, Inc.EXOZ
$17.52K
TEC
Bio-TechneTECH
$311.42M-1.5%
Revvity logo
RevvityRVTY
$729.69M+1.3%

Segments

By segment

See full
Reportable Segment$20.16M

Other financials

Income statement

See full
Gross profit$18.4M-45.4%
Operating income-$58.5M-0.7%
Net income-$46.7M+22.5%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$172.0M-31.6%
Total debt$404.1M-5.8%
Total equity$420.3M-31.4%
Total assets$990.0M-19.6%

Cash flow

See full
Operating cash flow-$44.3M-10.0%
CapEx$2.6M+6,792%
Free cash flow-$46.9M-16.4%

Valuation

See full
Market cap$520.64M-26.0%
Enterprise value$752.73M-14.6%
P/S4.7×+1.3×

Profitability

See full
Gross margin91.8%
Operating margin-259.9%+1,304pp
Net margin-260%+718pp
FCF margin-156.3%+38.7pp

Returns & leverage

See full
Return on equity-56.3%+23.1pp
Debt / equity+0.3×
Current ratio4.6×-0.8×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054298
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue (1)$20,156$39,134$39,630$77,364
Costs and operating expenses:
Cost of other revenue1,7195,3804,8179,470
Research and development46,21053,37096,130124,293
General and administrative30,77534,98168,60574,704
Restructuring charges3,5668,032
Total operating expenses78,70497,297169,552216,499
Loss from operations(58,548)(58,163)(129,922)(139,135)

Item 1. Financial Statements (Unaudited)

FAQ

What is Ginkgo Bioworks's total revenue?
Ginkgo Bioworks (DNA) reported total revenue of $20.16M in Q2 2026.
How has Ginkgo Bioworks's total revenue changed year-over-year?
Ginkgo Bioworks's total revenue decreased by 48.5% year-over-year, from $39.13M to $20.16M.
What is the long-term trend for Ginkgo Bioworks's total revenue?
Over 4 years (2021 to 2025), Ginkgo Bioworks's total revenue has grown at a -16.9% compound annual growth rate (CAGR), from $313.84M to $149.6M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Ginkgo Bioworks's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude